Menstrual mood disorders are associated with blunted sympathetic reactivity to stress

Journal of Psychosomatic Research

Volumn 76, Issue 1, 2014, Pages 46-55

  Klatzkin, Rebecca R ^a   Bunevicius, Adomas ^b   Forneris, Catherine A ^b   Girdler, Susan ^b  

^a RHODES COLLEGE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; Menstrually related mood disorders; Premenstrual dysphoric disorder; Reactivity; Stress; Sympathetic nervous system

Indexed keywords

NORADRENALIN;

ADULT; ANGER; ANXIETY; ANXIETY DISORDER; ARTICLE; CARDIOVASCULAR RESPONSE; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSTHYMIA; EATING DISORDER; EXERCISE TEST; FEMALE; HEART INDEX; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MENSTRUAL CYCLE; MENSTRUALLY RELATED MOOD DISORDER; MENSTRUATION; MENTAL STRESS; MIDDLE AGED; MOOD DISORDER; PREMENSTRUAL DYSPHORIC DISORDER; SUBSTANCE ABUSE;

DEPRESSION; MENSTRUALLY RELATED MOOD DISORDERS; PREMENSTRUAL DYSPHORIC DISORDER; REACTIVITY; STRESS; SYMPATHETIC NERVOUS SYSTEM;

ADULT; AFFECT; AFFECTIVE SYMPTOMS; BLOOD PRESSURE; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HEART RATE; HUMANS; MIDDLE AGED; NOREPINEPHRINE; PHENOTYPE; PREMENSTRUAL SYNDROME; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL;

EID: 84890807683     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2013.11.002     Document Type: Article

References (85)

1. Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen H Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res 2012, 21:169-184.
2. Hartlage SA, Freels S, Gotman N, Yonkers K Criteria for Premenstrual Dysphoric Disorder: secondary analyses of relevant data sets. Arch Gen Psychiatry 2012, 69:300-305.
3. Cunningham J, Yonkers KA, O'Brien S, Eriksson E Update on research and treatment of premenstrual dysphoric disorder. Harv Rev Psychiatry 2009, 17:120-137.
4. Biggs WS, Demuth RH Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Physician 2011, 84:918-924.
5. Halbreich U, Borenstein J, Pearlstein T, Kahn LS The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003, 28:1-23.
6. Pearlstein T, Steiner M Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci 2008, 33:291-301.
7. Freeman EW, Sondheimer SJ Premenstrual Dysphoric Disorder: recognition and treatment Prim Care Companion. J Clin Psychiatry 2003, 5:30-39.
8. Wittchen HU, Becker E, Lieb R, Krause P Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 2002, 32:119-132.
9. Bunevicius A, Leserman J, Girdler SS Hypothalamic-pituitary-thyroid axis function in women with a menstrually related mood disorder: association with histories of sexual abuse. Psychosom Med 2012, 74:810-816.
10. Bunevicius R, Hinderliter AL, Light KC, Leserman J, Pedersen CA, Girdler SS Histories of sexual abuse are associated with differential effects of clonidine on autonomic function in women with premenstrual dysphoric disorder. Biol Psychol 2005, 69:281-296.
11. Girdler SS, Sherwood A, Hinderliter AL, Leserman J, Costello NL, Straneva PA, et al. Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls. Psychosom Med 2003, 65:849-856.
12. Cohen LS, Soares CN, Otto MW, Sweeney BH, Liberman RF, Harlow BL Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard study of moods and cycles. J Affect Disord 2002, 70:125-132.
13. Pearlstein TB, Frank E, Rivera-Tovar A, Thoft JS, Jacobs E, Mieczkowski TA Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder. J Affect Disord 1990, 20:129-134.
14. Yonkers KA The association between premenstrual dysphoric disorder and other mood disorders. J Clin Psychiatry 1997, 58:19-25.
15. Harrison WM, Endicott J, Nee J, Glick H, Rabkin JG Characteristics of women seeking treatment for premenstrual syndrome. Psychosomatics 1989, 30:405-411.
16. Hartlage SA, Arduino KE, Gehlert S Premenstrual dysphoric disorder and risk for major depressive disorder: a preliminary study. J Clin Psychol 2001, 57:1571-1578.
17. Graze KK, Nee J, Endicott J Premenstrual depression predicts future major depressive disorder. Acta Psychiatr Scand 1990, 81:201-205.
18. Roca CA, Schmidt PJ, Rubinow DR A follow-up study of premenstrual syndrome. J Clin Psychiatry 1999, 60:763-766.
19. Kendler KS, Karkowski LM, Corey LA, Neale MC Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am J Psychiatry 1998, 155:1234-1240.
20. Endicott J, Amsterdam J, Eriksson E, Frank E, Freeman E, Hirschfeld R, et al. Is premenstrual dysphoric disorder a distinct clinical entity?. J Womens Health Gend Based Med 1999, 8:663-679.
21. Girdler SS, Pedersen CA, Stern RA, Light KC Menstrual cycle and premenstrual syndrome: modifiers of cardiovascular reactivity in women. Health Psychol 1993, 12:180-192.
22. Girdler SS, Pedersen CA, Straneva PA, Leserman J, Stanwyck CL, Benjamin S, et al. Dysregulation of cardiovascular and neuroendocrine responses to stress in premenstrual dysphoric disorder. Psychiatry Res 1998, 81:163-178.
23. Fontana AM, Badawy S Perceptual and coping processes across the menstrual cycle: an investigation in a premenstrual syndrome clinic and a community sample. Behav Med 1997, 22:152-159.
24. Ravindran AV, Griffiths J, Waddell C, Anisman H Stressful life events and coping styles in relation to dysthymia and major depressive disorder: variations associated with alleviation of symptoms following pharmacotherapy. Prog Neuropsychopharmacol Biol Psychiatry 1995, 19:637-653.
25. Kendler KS, Kuhn JW, Prescott CA Childhood sexual abuse, stressful life events and risk for major depression in women. Psychol Med 2004, 34:1475-1482.
26. Morris MC, Ciesla JA, Garber J A prospective study of stress autonomy versus stress sensitization in adolescents at varied risk for depression. J Abnorm Psychol 2010, 119:341-354.
27. Paddison PL, Gise LH, Lebovits A, Strain JJ, Cirasole DM, Levine JP Sexual abuse and premenstrual syndrome: comparison between a lower and higher socioeconomic group. Psychosomatics 1990, 31:265-272.
28. Lee EE, Nieman LK, Martinez PE, Harsh VL, Rubinow DR, Schmidt PJ ACTH and cortisol response to DEX/CRH testing in women with and without premenstrual dysphoria during GNRH agonist-induced hypogonadism and ovarian steroid replacement. Clin Endocrinol Metab 2012, 97:1887-1896.
29. Chuong CJ, Coulam CB, Kao PC, Bergstralh EJ, Go VL Neuropeptide levels in premenstrual syndrome. Fertil Steril 1985, 44:760-765.
30. Facchinetti F, Fioroni L, Martignoni E, Sances G, Costa A, Genazzani AR Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome. Psychosom Med 1994, 56:418-422.
31. Giannini AJ, Martin DM, Turner CE Beta-endorphin decline in late luteal phase dysphoric disorder. Int J Psychiatry Med 1990, 20:279-284.
32. Straneva PA, Maixner W, Light KC, Pedersen CA, Costello NL, Girdler SS Menstrual cycle, beta-endorphins, and pain sensitivity in premenstrual dysphoric disorder. Health Psychol 2002, 21:358-367.
33. Bancroft J, Cook A, Davidson D, Bennie J, Goodwin G Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change. Psychol Med 1991, 21:305-312.
34. Su TP, Schmidt PJ, Danaceau M, Murphy DL, Rubinow DR Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. J Clin Endocrinol Metab 1997, 82:1220-1228.
35. Klatzkin RR, Lindgren ME, Forneris CA, Girdler SS Histories of major depression and premenstrual dysphoric disorder: evidence for phenotypic differences. Biol Psychol 2010, 84:235-247.
36. Girdler S, Klatzkin R Biological responses to stress in premenstrual dysphoric disorder: influence of histories of abuse and depression. Gynaecol Forum 2006, 11:27-32.
37. Gillespie CF, Nemeroff CB Hypercortisolemia and depression. Psychosom Med 2005, 67:S26-S28.
38. Holsboer F The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23:477-501.
39. Carney RM, Freedland KE, Veith RC, Cryer PE, Skala JA, Lynch T, et al. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry 1999, 45:458-463.
40. Gold PW, Wong ML, Goldstein DS, Gold HK, Ronsaville DS, Esler M, et al. Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci U S A 2005, 102:8303-8308.
41. Hamer M, Tanaka G, Okamura H, Tsuda A, Steptoe A The effects of depressive symptoms on cardiovascular and catecholamine responses to the induction of depressive mood. Biol Psychol 2007, 74:20-25.
42. Lake CR, Pickar D, Ziegler MG, Lipper S, Slater S, Murphy DL High plasma norepinephrine levels in patients with major affective disorder. Am J Psychiatry 1982, 139:1315-1318.
43. Lechin F, van der Dijs B, Orozco B, Lechin ME, Baez S, Lechin AE, et al. Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients. Biol Psychiatry 1995, 38:166-173.
44. Udupa K, Sathyaprabha TN, Thirthalli J, Kishore KR, Lavekar GS, Raju TR, et al. Alteration of cardiac autonomic functions in patients with major depression: a study using heart rate variability measures. J Affect Disord 2007, 100:137-141.
45. Veith RC, Lewis N, Linares OA, Barnes RF, Raskind MA, Villacres EC, et al. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry 1994, 51:411-422.
46. Volkers AC, Tulen JH, van den Broek WW, Bruijn JA, Passchier J, Pepplinkhuizen L Motor activity and autonomic cardiac functioning in major depressive disorder. J Affect Disord 2003, 76:23-30.
47. Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A 2000, 97:325-330.
48. Broadley AJ, Frenneaux MP, Moskvina V, Jones CJ, Korszun A Baroreflex sensitivity is reduced in depression. Psychosom Med 2005, 67:648-651.
49. Bhagwagar Z, Hafizi S Cowen PJ3. Increase in concentration of waking salivary cortisol in recovered patients with depression. Am J Psychiatry 2003, 160:1890-1891.
50. Vreeburg SA, Hoogendijk WJG, van Pelt J, DeRijk RH, Verhagen JCM, van Dyck R, et al. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity results from a large cohort study. Arch Gen Psychiatry 2009, 66:617-626.
51. Kathol RG Persistent elevation of urinary free cortisol and loss of circannual periodicity in recovered depressive patients. A trait finding. J Affect Disord 1985, 8:137-145.
52. Young EA, Aggen SH, Prescott CA, Kendler KS Similarity in saliva cortisol measures in monozygotic twins and the influence of past major depression. Biol Psychiatry 2000, 48:70-74.
53. Lok A, Mocking RJT, Ruhe' HG, Visser I, Koeter MWJ, Assies J, et al. Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression. Psychoneuroendocrinology 2012, 37:892-902.
54. Bagley SL, Weaver TL, Buchanan TW Sex differences in physiological and affective responses to stress in remitted depression. Physiol Behav 2011, 104:180-186.
55. Girdler SS, Lindgren M, Porcu P, Rubinow DR, Johnson JL, Morrow AL A history of depression in women is associated with an altered GABAergic neuroactive steroid profile. Psychoneuroendocrinology 2012, 37:543-553.
56. Ahrens T, Deuschle M, Krumm B, van der Pompe G, den Boer JA, Lederbogen F Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression. Psychosom Med 2008, 70:461-467.
57. Morris MC, Rao U, Garber J Cortisol responses to psychosocial stress predict depression trajectories: social-evaluative threat and prior depressive episodes as moderators. J Affect Disord 2012, 143:223-230.
58. Endicott J, Nee J, Harrison W Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Womens Ment Health 2006, 9:41-49.
59. Rubinow DR, Roy-Byrne PP, Hoban MC, Gold PW, Post RM Prospective assessment of menstrually related mood disorders. Am J Psychiatry 1984, 141:684-686.
60. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59:22-33.
61. Stoney CM, Owens JF, Matthews KA, Davis MC, Caggiula A Influences of the normal menstrual cycle on physiologic functioning during behavioral stress. Psychophysiology 1998, 27:125-135.
62. Weidner G, Helmig L Cardiovascular stress reactivity and mood during the menstrual cycle. Women Health 1999, 16:5-21.
63. Fleischman DS, Bunevicius A, Leserman J, Girdler SS Menstrually related mood disorders and a history of abuse: moderators of pain sensitivity. Health Psychol March 25 2013, [Epub ahead of print, in press].
64. Kirschbaum C, Pirke KM, Hellhammer DH The 'Trier Social Stress Test' - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993, 28:76-81.
65. Kirschbaum C, Klauer T, Filipp SH, Hellhammer DH Sex-specific effects of social support on cortisol and participantive responses to acute psychological stress. Psychosom Med 1995, 57:23-31.
66. Kirschbaum C, Prussner JC, Stone AA, Federenko I, Gaab J, Lintz D, et al. Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men. Psychosom Med 1995, 57:468-474.
67. Gronwall DM Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 1977, 44:367-373.
68. Dimsdale JE, Ziegler MG What do plasma and urinary measures of catecholamines tell us about human response to stressors?. Circulation 1991, 83:36-42.
69. Sherwood A, Allen MT, Fahrenberg J, Kelsey RM, Lovallo WR, van Doornen LJP Methodological guidelines for impedance cardiography. Psychophysiology 1990, 27:1-23.
70. Kubicek WG, Krnegis JN, Patterson RP, Witsoe DA, Mattson RH Development an evaluation of impedance cardiac output system. Aerosp Med 1996, 37:1208-1212.
71. Blake F, Salkovskis P, Gath D, Day A, Garrod A Cognitive therapy for premenstrual syndrome: a controlled trial. J Psychosom Res 1998, 45:307-318.
72. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998, 338:209-216.
73. Foster PS, Goldie RG, Patterson JW Effect of steroids on b-adrenoceptor-mediated relaxation of pig bronchus. Br J Pharmacol 1983, 78:441-445.
74. Heal DJ, Bristow LJ, DeSouza RJ, Bloomfield JG, Hurst EM, Elliott JM The influence of injection of estradiol to female rats on changes in a2- and b-adrenoceptor function induced by repeated administration of desipramine or electroconvulsive shock. Neuropharmacology 1998, 27:1151-1159.
75. Maggi A, Zucchi I, Perez J Progesterone in rat brain: modulation of b-adrenergic receptor activity. Pharmacol Res Commun 1985, 17:283-291.
76. Wheeldon NM, Newnham DM, Coutie WJ, Peters JA, McDevitt DG, Lipworth BJ Influence of sex-steroid hormones on the regulation of lymphocyte beta 2-adrenoceptors during the menstrual cycle. Br J Clin Pharmacol 1994, 37:583-588.
77. Gurguis GN, Yonkers KA, Blakeley JE, Phan SP, Williams A, Rush AJ Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity. Psychiatry Res 1998, 79:31-42.
78. Phillips AC, Hunt K, Der G, Carroll D Blunted cardiac reactions to acute psychological stress predict symptoms of depression five years later: evidence from a large community study. Psychophysiology 2011, 48:142-148.
79. Girdler SS, Leserman J, Bunevicius R, Klatzkin R, Pedersen CA, Light KC Persistent alterations in biological profiles in women with abuse histories: influence of premenstrual dysphoric disorder. Health Psychol 2007, 26:201-213.
80. McEwen BS Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci 1998, 1:33-44.
81. Siever LJ, Davis KL Overview: toward a dysregulation hypothesis of depression. Am J Psychiatry 1985, 142:1017-1031.
82. Juster RP, McEwen BS, Lupien SJ Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev 2010, 35:2-16.
83. Robinson MS, Alloy LB Negative cognitive styles and stress-reactive rumination interact to predict depression: a prospective study. Cogn Ther Res 2003, 27:275-292.
84. Alloy LB, Abramson LY, Whitehouse WG, Hogan ME, Panzarella C, Rose DT Prospective incidence of first onsets and recurrences of depression in individuals at high and low cognitive risk for depression. J Abnorm Psychol 2006, 115:145-156.
85. Mechlin MB, Maixner W, Light KC, Fisher JM, Girdler SS African Americans show alterations in endogenous pain regulatory mechanisms and reduced pain tolerance to experimental pain procedures. Psychosom Med 2005, 67:948-956.